Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Devices in Acne and Rosacea: Best Practices

Description

The presentation, titled "Devices in Acne and Rosacea: Best Practices," discusses the evolving role of lasers and devices in treating acne and rosacea. The speaker, who has experience with both traditional medications and devices, highlights the advancements made over the last nine years in this area. Initially, evidence supporting the effectiveness of lasers and devices for acne was limited, but recent developments, particularly with 1726 nanometer lasers, show promising results. These lasers, FDA-cleared in 2022, directly target sebum production, providing potential for significant acne reduction and improved treatment longevity, although multiple sessions are often required. Overviews of various devices, including photodynamic therapy and intense pulse light mechanisms, illustrate their distinct approaches to acne treatment. The speaker also shares comparative data from clinical trials, affirming substantial decreases in inflammatory lesions post-treatment, emphasizing the devices' potential for patients seeking alternative treatments. Regarding rosacea, the speaker notes that while lasers effectively treat persistent erythema, they struggle with transient flushing. The presenter concludes by emphasizing the importance of lasers not just as cosmetic tools but as significant options for improving patients' quality of life for both acne and rosacea, encouraging medical professionals to consider these technologies in their treatment plans.

View more

Conclusions

  • Lasers and light devices have evolving roles in treating acne and rosacea, with FDA clearance showing new options.
  • The most established evidence for laser use in acne treatment as of 2024 shows improvement primarily with photodynamic therapy.
  • 1726 nm lasers demonstrate targeted effectiveness in reducing inflammatory lesions and are FDA cleared for mild to severe acne.
  • These treatments often require multiple sessions and do not replace traditional medications but provide an additional option for patients.
  • Clinical trials indicate significant reduction in lesion counts with the 1726 nm laser across various skin types and during long-term follow-up periods.
  • Lasers and light therapies effectively improve quality of life for patients suffering from acne and rosacea.
  • In treating rosacea, laser therapies are more effective for persistent erythema than for transient flushing.
  • The safety profile of these devices includes minimal side effects, primarily erythema that resolves quickly after treatment.
  • Zaenglein, Andrea L., et al. "Guidelines of care for the management of acne vulgaris." Journal of the American Academy of Dermatology 74.5 (2016): 945-973.
  • Reynolds, Rachel V., et al. "Guidelines of care for the management of acne vulgaris." Journal of the American Academy of Dermatology (2024).
  • Alexiades, Macrene, et al. "Novel 1726 nm Laser Demonstrates Durable Therapeutic Outcomes and Tolerability for Moderate-to-Severe Acne Across Skin Types." Journal of the American Academy of Dermatology (2023).
  • Goldberg, et al. A safe and effective solution for acne vulgaris. Journal of Cosmetic Dermatology. 2022.
  • Neuhaus, Isaac M., Lee T. Zane, and Whitney D. Tope. "Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea." Dermatologic surgery 35.6 (2009): 920-928.
  • Kim, Bo Young, Hye-Rim Moon, and Hwa Jung Ryu. "Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea." Journal of Cosmetic and Laser Therapy 21.5 (2019): 291-296.
  • Shim TN, Abdullah A. The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment. J Clin Aesthet Dermatol. 2013;6(4):30-32.